Northwestern Medicine scientists used “big data” tools to classify for the first time three distinct categories of a common heart failure syndrome. The findings may be used to better predict how diverse patients will respond to treatments.
A Northwestern Medicine study estimated the incidence and etiology of community-acquired pneumonia in children and found that respiratory viruses were more commonly detected in children with pneumonia than bacterial pathogens, suggesting that new anti-viral vaccines or treatments could reduce the overall burden of pediatric pneumonia.
Xunrong Luo, MD, PhD, associate professor in Medicine-Nephrology, Microbiology-Immunology and Surgery-Organ Transplantation, has been selected to receive the American Society of Transplantation Basic Science Investigator Award.
Chad Mirkin, PhD, and colleagues show that spherical nucleic acids can be used to regulate immune responses in a new study that could shift the way scientists think about developing therapeutic agents for many diseases.
Northwestern Medicine scientists have identified mechanisms behind desmosomes, important junctions that bind cells together, helping to explain how some skin and heart diseases develop.
Feinberg is one of the nation’s top 20 medical schools in the annual U.S. News & World Report rankings, with women’s health, internal medicine and pediatrics positioned highly in medical specialty rankings.
A new study shows that teenagers who had previously been heavy users of marijuana performed worse on long-term memory tests than those who never used cannabis, and they had abnormally shaped hippocampuses.
A Northwestern Medicine study found that standard treatments for metastatic melanoma are not effective against Nodal, a growth factor protein critical for the skin cancer’s development, but also showed that combination therapies incorporating anti-Nodal antibodies are a promising alternative.
Northwestern Medicine scientists have developed a method to systematically explore diverse natural resources, allowing them to quickly identify thousands of compounds from bacteria that have potential to become new pharmaceuticals.
Robert Schleimer, PhD, chief of Division of Medicine Allergy-Immunology and Roy Patterson Professor of Medicine, has been named the winner of the Tripartite Legacy Faculty Prize in Translational Science and Education.